查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1146218

冷藏培養箱市場-增長、趨勢、COVID-19 影響和預測 (2022-2027)

Refrigerated Incubators Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計冷藏培養箱市場在預測期內（2022 年至 2027 年）的複合年增長率為 5.6%。

COVID-19 帶來了重大挑戰，並將醫療和保健社區推向了極限。醫院陷入困境是因為疾病的傳播速度快於公司製造個人防護設備 (PPE) 和供應所需醫療用品的速度。但供應只是 COVID-19 給醫療器械行業帶來的眾多挑戰之一。製冷行業是在抗擊冠狀病毒 (COVID-19) 大流行的幕後發揮關鍵作用的行業之一。從保持適當的溫度，到藥品的安全運輸和儲存，再到位於大廳和停車場等公共場所的傳統醫療機構和急救醫院中患者和護理人員的安全和舒適。我負責一切。藥品需要嚴密的溫度控制和監測，以符合行業法規和藥品安全指南。儘管 COVID-19 造成了致命影響，但它對低溫培養箱市場產生了重大的積極影響。

此外，在傳染病研究活動中越來越多地採用冷藏培養箱，以及冷藏培養箱技術的不斷進步是推動所研究市場增長的主要因素。日益嚴重的傳染病威脅正在造成社會和經濟風險。流行病和流行病佔與醫療干預和傳染病控制相關的醫療保健費用的大部分。例如，COVID-19 大流行已在世界各地造成重大生命損失，並對公共衛生、食品系統和工作場所構成前所未有的威脅。冷卻培養箱的需求量越來越大，因為它們被旨在開發疫苗的研究人員用作工具。臨床試驗證實，來自Pfizer生物科技和Moderna的兩款冠狀病毒疫苗有效率超過90%。Pfizer的疫苗需要在-70°C下長期儲存，而Moderna的疫苗需要在-20°C下長期儲存。 （兩者都可以在 2°C 至 8°C 的普通冰箱中短時間儲存）。 Oxford/AstraZeneca 疫苗可以在普通冰箱環境中長期儲存和運輸。這些因素可能會推動冷藏培養箱的採用，並有助於所研究市場的增長。

還有一些技術特性，例如密碼保護設置、開門警報、自動去污循環、自校準、預設警報、超溫警報、即使在高溫環境下也能實現安全和可重複孵化的恆溫器。進步和最新趨勢預計將在預測期內推動冷藏培養箱的銷售。例如，Thermo Scientific 的新型冷藏培養箱採用強大的壓縮機技術，非常適合需要高於、大約或低於正常實驗室環境溫度的熱穩定性和均勻性的應用。旨在提供溫度條件。

此外，市場主要參與者的新產品發布和戰略活動對所研究市場的增長產生了積極影響。例如，2022 年 1 月，北美 PHC 公司推出了一款新型高性能台下式冷凍櫃，旨在提供精確的溫度控制和均勻性。 PF-L5181W-PA 符合 CDC（美國疾病控制與預防中心）指南，可將溫度保持在 -15°C 至 -25°C 之間。無論該裝置是滿載還是空載，它都旨在保持 ±5°C 的嚴格均勻性，以存儲關鍵疫苗和生物製品。此外，2019 年 1 月，Gilson 宣布推出一系列新的台式儀器，可提供樣品混合、溫度控制和離心功能。該儀器採用先進技術，可提高實驗室生產力並節省寶貴時間。因此，由於產品發布和收購，預計該市場在預測期內將出現顯著增長。

因此，由於上述因素，預計所研究的市場在分析期內將增長。然而，替代孵化器的可用性可能會阻礙市場增長。

主要市場趨勢

51-200L 細分市場有望在預測期內實現顯著的高增長

51-200L 冷藏培養箱是一款功能強大、高效的便攜式裝置，由內部風扇組成，可防止熱分層並保持穩定的溫度。此外，實時控制可以減少日常人工作業和設備的重複操作。 51-200L 低溫培養箱經常用於微生物分析、細菌計數、高於和低於室溫的生物樣品培養以及促進老化研究。根據 Clinical Trials.gov 的一份報告，紐約幹細胞基金會 (NYSCF) 將在 2021 年利用乾細胞和其他類型的細胞來研究生物樣本/樣本，進行基因檢測，並供將來使用。我們正在進行研究短期儲存這些樣本以研究各種狀況和疾病。這些因素正在推動美國實驗室採用冷藏培養箱。此外，根據在美國舉行的第二屆細胞與基因治療國際會議，大學校園內有超過40,000個個體實驗室參與生物學和生物醫學領域的發展，僅此而已。因此，上述因素有望增加這些產品在目標人群中的採用率，並推動市場增長。

此外，市場主要參與者推出的產品對該細分市場的增長產生了積極影響。例如，2020 年 8 月，北美 PHC 公司發布了一款專為疫苗和生物製劑的存儲而設計的新型高性能 MPR-S300H-PA-PA，其中精確的溫度控制對於存儲產品的安全至關重要。推出了 ECO 製藥冰箱。因此，由於上述因素，預計 51-200L 細分市場在預測期內將出現顯著增長。

冷藏培養箱市場有望由北美主導

由於傳染病上升、人口老齡化和產品批准數量增加等因素，預計北美將主導市場。例如，根據美國聯邦人口公報 (PBA) 的數據，美國 65 歲以上的人口數量將增加近一倍，從 2018 年的 5200 萬增加到 2060 年的 9500 萬，佔總人口的 16%。預計增加到 23%。根據美國疾病控制和預防中心 2021 年 10 月發布的數據，老年人口更容易受到感染。總體而言，2019-2020 流感季報告了 3500 萬例與流感相關的疾病、38 萬例與流感相關的住院治療、2 萬例與流感相關的死亡以及 1600 萬例與流感相關的醫院就診。這些是促進北美研究目標市場增長的關鍵因素。

關鍵產品的消息、市場參與者的高度集中或製造商在美國的存在是推動該國冷藏培養箱市場增長的一些因素。例如，2021 年 2 月，Middleby Corporation 的一個部門 Follett Products, LLC (Follett) 和 PHC Corporation of North America (PHCNA) 將提供超低溫 (ULT) 冷凍機、醫藥級冷凍機，我們已經宣布了一項與 PHCbi 系列生物醫學冰箱的銷售合作。預計該地區持續的產品批准將推動市場的增長。因此，由於上述因素，預計北美地區的市場增長。

競爭格局

由於多家公司在全球和區域運營，因此冷藏培養箱市場本質上是分散的。競爭格局包括具有市場份額的知名國際公司和本地公司分析。 KG、Benchmark Scientific、Gilson, Inc. 等

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 在針對傳染病的研究活動中更多地採用冷藏培養箱
    • 冷卻培養箱技術進步的增加
  • 市場製約因素
    • 替代孵化器的可用性
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按類型
    • 小於 50L
    • 51-200 升
    • 201-750L
    • 751-1500 升
    • 1501L 或以上
  • 通過使用
    • 醫院
    • 研究機構和學術機構
    • 製藥公司、生物技術公司
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Binder GmbH
    • Thermo Fisher Scientific
    • PHC Holdings Corporation
    • Eppendorf AG
    • Amerex Instruments, Inc.
    • Sheldon Manufacturing, Inc.
    • LEEC Ltd.
    • Memmert GmbH+Co. KG
    • Benchmark Scientific
    • Gilson, Inc.

第七章市場機會與未來趨勢

簡介目錄
Product Code: 91683

The refrigerated incubators market is expected to register a CAGR of 5.6% over the forecast period (2022-2027).

COVID-19 has greatly challenged the medical and healthcare communities and pushed them to the limits. Hospitals struggle as the disease spreads faster than the companies can produce Personal Protective Equipment (PPE) and supply the necessary medical supplies. But supply is just one of the many challenges that COVID-19 presents to the medical device industry. The cooling industry is one of the sectors that play a crucial part in the fight against the coronavirus (COVID-19) pandemic from behind the scenes. It takes care of everything from maintaining the proper temperature to safely transporting and storing medicines, as well as keeping patients and caregivers safe and comfortable in both traditional healthcare facilities and emergency hospitals set up in halls, parking lots, and other public spaces. Pharma products require close temperature control and monitoring to comply with industry regulations and pharmaceutical safety guidelines. Despite the deadly effect of COVID-19, there is a significant positive impact on the refrigerated incubators market.

Further, the rising adoption of refrigerated incubators for research activities targeting infectious diseases and the increasing technological advancements in refrigerated incubators are among the major factors driving the growth of the studied market. The rising threat of infectious diseases is responsible for creating social and economic risks. Epidemics and pandemics are responsible for a significant part of the healthcare costs associated with medical treatment and outbreak control. For example, the COVID-19 pandemic has resulted in a significant loss of human life around the world and poses an unprecedented threat to public health, food systems, and the workplace. The demand for refrigerated incubators is rising as they are used as tools by researchers who are trying to develop a vaccine. In clinical studies, two coronavirus vaccines - one from Pfizer-BioNTech and the other from Moderna - were found to be more than 90% effective. The Pfizer vaccine requires long-term storage at -70°C, while the Moderna vaccine required long-term storage at -20°C. (Both can be kept for a short time in a normal refrigerator at 2°C to 8°C.) The Oxford/AstraZeneca vaccine can be kept and carried for a long time at ordinary fridge settings. Such factors are likely to boost the adoption of refrigerated incubators, thereby contributing to the studied market growth.

Also, technological advancements and the latest trends in the refrigerated incubator market, such as password-protected settings, door opening alarms, auto decontamination cycles, self-calibration, pre-set alarms, over-temperature alarms, and thermostats, safe, reproducible incubation, and even at high ambient temperatures are expected to drive the sales of refrigerated incubators during the forecast period. For instance, the new Thermo Scientific refrigerated incubators utilize powerful compressor technology designed to provide optimal temperature conditions for applications that require thermal stability and uniformity above, around, or below the usual ambient laboratory temperature.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, in January 2022, PHC Corporation of North America introduced a new, high-performance undercounter freezer designed to provide precise temperature control and uniformity. The PF-L5181W-PA meets Centers for Disease Control and Prevention (CDC) guidelines and maintains temperatures between -15°C and -25°C. It has been engineered to maintain a tight uniformity of ±5°C for storing critical vaccines and biologics whether the unit is loaded or empty. Additionally, In January 2019, Gilson announced the launch of a new benchtop instrumentation product line offering mixing, temperature control, and centrifugation of samples. The instruments feature advanced technologies that improve lab productivity and save valuable time. Thus, owing to the product launches and acquisitions, the studied market is expected to have significant growth over the forecast period.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the availability of alternative incubators is likely to impede market growth.

Key Market Trends

51-200L Segment is Expected to Witness Significant High Growth Over the Forecast Period

51-200L refrigerated incubators comprise powerful and highly efficient portable units, consisting of an internal fan for preventing thermal layering and keeping a consistent temperature. Such incubators reduce daily manual tasks and repetitive operations on the instruments through real-time control. Frequent applications of 51-200L refrigerated incubators type involve microbiological analyses, determining germ count, biological specimen cultivation above and below room temperature and accelerating aging tests. According to the Clinical Trials.gov report, the New York Stem Cell Foundation (NYSCF) in 2021, conducts research, to study various conditions and diseases by utilising stem cells and other types of cells, conducting research on biological specimens/samples, performing genetic testing, and storing these samples for short periods of time for future use. Such factors highly support the adoption of refrigerated incubators in the United States laboratories. Further, according to the second international conference of cell and gene therapy in the US alone, there are more than 40,000 individual research laboratories located on university campuses involved in advancing the field of biological and biomedical sciences. Hence, owing to the above factors, the adoption of these products is likely to increase among the target population, driving market growth.

Furthermore, the product launches by major players in the market are positively affecting the growth of the segment. For instance, in August 2020 PHC Corporation of North America introduced a new, high-performance MPR-S300H-PA-PA ECO pharmaceutical refrigerator designed for vaccine and biologics storage where precise temperature control is essential for stored product safety. Therefore, the 51-200L segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Refrigerated Incubators Market

North America is expected to dominate the market owing to factors such as the growing number of infectious diseases, coupled with the rising geriatric population and the rising number of product approvals. For instance, according to the Bureau's Population Bulletin(PBA), the number of Americans 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060, and the overall percentage of the population will increase from 16 percent to 23 percent. According to data published by the Centers for Disease Control and Prevention in October 2021, the geriatric population is more vulnerable to infectious diseases. Overall, 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits were reported in the 2019-2020 season. These are the key factors that contribute to the growth of the studied market in North America.

Key product news, high concentration of market players, or manufacturer's presence in the United States are some of the factors driving the growth of the refrigerated incubators market in the country. For instance, In February 2021 Follett Products, LLC (Follett), a division of The Middleby Corporation, and PHC Corporation of North America (PHCNA) have announced the formation of a partnership to market and sell the PHCbi line of ultra-low temperature (ULT) freezers, pharmaceutical grade refrigerators, and biomedical freezers to Follett's healthcare customers. These continuous product approvals in the region are anticipated to drive the growth of the market in the country. Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The refrigerated incubators market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Binder GmbH, Thermo Fisher Scientific, PHC Holdings Corporation, Eppendorf AG, Amerex Instruments, Inc., Sheldon Manufacturing, Inc., LEEC Ltd., Memmert GmbH + Co. KG, Benchmark Scientific and Gilson, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising adoption of refrigerated incubators for research activities targeting infectious diseases
    • 4.2.2 Increasing technological advancements in refrigerated incubators
  • 4.3 Market Restraints
    • 4.3.1 Availability of alternative incubators
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Below 50L
    • 5.1.2 51-200L
    • 5.1.3 201-750L
    • 5.1.4 751-1500L
    • 5.1.5 Above 1501L
  • 5.2 By Application
    • 5.2.1 Hospitals
    • 5.2.2 Research Laboratories and Acedmic Institues
    • 5.2.3 Pharmaceutical and Biotechnology Companies
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Binder GmbH
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 PHC Holdings Corporation
    • 6.1.4 Eppendorf AG
    • 6.1.5 Amerex Instruments, Inc.
    • 6.1.6 Sheldon Manufacturing, Inc.
    • 6.1.7 LEEC Ltd.
    • 6.1.8 Memmert GmbH + Co. KG
    • 6.1.9 Benchmark Scientific
    • 6.1.10 Gilson, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS